# Arbutus Biopharma Corp: Form DEF 14A, filed Apr 11, 2022

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: DEF 14A
- Filed: 2022-04-11
- Accepted by EDGAR: Apr 11, 2022, 16:05 ET
- Period: 2022-05-25
- Accession: 0001140361-22-013967
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000114036122013967/edge20002217x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000114036122013967/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000114036122013967/edge20002217x1_def14a.htm

Filed Apr 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-013967. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.